The FDA and safe use of long-acting beta-agonists in the treatment of asthma.

作者信息

Chowdhury Badrul A, Dal Pan Gerald

机构信息

Division of Pulmonary and Allergy Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

出版信息

N Engl J Med. 2010 Apr 1;362(13):1169-71. doi: 10.1056/NEJMp1002074. Epub 2010 Feb 24.

DOI:10.1056/NEJMp1002074

PMID:20181964

Abstract

摘要

相似文献

[1]

The FDA and safe use of long-acting beta-agonists in the treatment of asthma.

N Engl J Med. 2010-4-1

[2]

Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.

N Engl J Med. 2009-4-16

[3]

Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma.

N Engl J Med. 2011-6-30

[4]

[Long acting beta-2 agonists. Discussion of their use in asthma].

MMW Fortschr Med. 2009-4-9

[5]

Long-acting beta agonists--prescribe with care.

N Z Med J. 2006-7-7

[6]

FDA LABA warning: is there anything new here?

Clin Pharmacol Ther. 2010-6

[7]

[How risky are beta-2 mimetics?].

MMW Fortschr Med. 2006-8-17

[8]

[Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma].

Pneumologie. 2010-6

[9]

Safety of long-acting beta-agonists.

N Engl J Med. 2006-3-16

[10]

The US Food and Drug Administration and long-acting beta2-agonists: the importance of striking the right balance between risks and benefits of therapy?

J Allergy Clin Immunol. 2010-9

引用本文的文献

[1]

The Wiser Strategy of Using Beta-Agonists in Asthma: Mechanisms and Rationales.

Allergy Asthma Immunol Res. 2024-5

[2]

Impact of treatment adherence and inhalation technique on asthma outcomes of pediatric patients: a longitudinal study.

Front Pharmacol. 2024-3-13

[3]

The Saudi initiative for asthma - 2024 update: Guidelines for the diagnosis and management of asthma in adults and children.

Ann Thorac Med. 2024

[4]

Inhaled drug delivery for the targeted treatment of asthma.

Adv Drug Deliv Rev. 2023-7

[5]

The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children.

Ann Thorac Med. 2021

[6]

No Evidence of Off-label Use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands: A Drug Utilization Study.

Sci Rep. 2020-1-17

[7]

Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy.

Front Pharmacol. 2019-5-21

[8]

The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children.

Ann Thorac Med. 2019

[9]

Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD.

Int J Chron Obstruct Pulmon Dis. 2018-12-27

[10]

Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.

Drug Saf. 2018-5

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

The FDA and safe use of long-acting beta-agonists in the treatment of asthma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献